572 related articles for article (PubMed ID: 17699009)
41. Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
Guercio BJ; Zhang S; Niedzwiecki D; Li Y; Babic A; Morales-Oyarvide V; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Zoltick ES; Stampfer M; Ng K; Wu K; Willett WC; Giovannucci EL; Meyerhardt JA; Fuchs CS
PLoS One; 2018; 13(7):e0199244. PubMed ID: 30024889
[TBL] [Abstract][Full Text] [Related]
42. Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance).
Lee S; Ma C; Shi Q; Meyers J; Kumar P; Couture F; Kuebler P; Krishnamurthi S; Lewis D; Tan B; O'Reilly EM; Shields AF; Meyerhardt JA
Br J Cancer; 2023 Aug; 129(2):283-290. PubMed ID: 37179438
[TBL] [Abstract][Full Text] [Related]
43. Cancer recurrence and survival associated with dietary patterns in stage III colon cancer.
Chu DZ
JAMA; 2007 Nov; 298(19):2263; author reply 2263. PubMed ID: 18029829
[No Abstract] [Full Text] [Related]
44. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
45. Dietary patterns, meat intake, and the risk of type 2 diabetes in women.
Fung TT; Schulze M; Manson JE; Willett WC; Hu FB
Arch Intern Med; 2004 Nov; 164(20):2235-40. PubMed ID: 15534160
[TBL] [Abstract][Full Text] [Related]
46. Obesity and Its Impact on Outcomes in Patients With Stage III Colon Cancer Receiving Adjuvant Chemotherapy.
Ding PQ; Batra A; Xu Y; McKinnon GP; Cheung WY
Clin Colorectal Cancer; 2020 Sep; 19(3):209-218. PubMed ID: 32291245
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
49. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
50. Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
Lee S; Zhang S; Ma C; Ou FS; Wolfe EG; Ogino S; Niedzwiecki D; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Gross CP; Irwin ML; Meyerhardt JA; Fuchs CS
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104867
[TBL] [Abstract][Full Text] [Related]
51. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
[TBL] [Abstract][Full Text] [Related]
52. Eating patterns and risk of colon cancer.
Slattery ML; Boucher KM; Caan BJ; Potter JD; Ma KN
Am J Epidemiol; 1998 Jul; 148(1):4-16. PubMed ID: 9663397
[TBL] [Abstract][Full Text] [Related]
53. Dietary patterns and survival after breast cancer diagnosis.
Kroenke CH; Fung TT; Hu FB; Holmes MD
J Clin Oncol; 2005 Dec; 23(36):9295-303. PubMed ID: 16361628
[TBL] [Abstract][Full Text] [Related]
54. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
[TBL] [Abstract][Full Text] [Related]
55. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
56. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial.
Protic M; Stojadinovic A; Nissan A; Wainberg Z; Steele SR; Chen DC; Avital I; Bilchik AJ
J Am Coll Surg; 2015 Sep; 221(3):643-51; quiz 783-5. PubMed ID: 26213360
[TBL] [Abstract][Full Text] [Related]
58. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
[TBL] [Abstract][Full Text] [Related]
59. Hospital lymph node examination rates and survival after resection for colon cancer.
Wong SL; Ji H; Hollenbeck BK; Morris AM; Baser O; Birkmeyer JD
JAMA; 2007 Nov; 298(18):2149-54. PubMed ID: 18000198
[TBL] [Abstract][Full Text] [Related]
60. Outcome of colon cancer initially presenting as colon perforation and obstruction.
Chen TM; Huang YT; Wang GC
World J Surg Oncol; 2017 Aug; 15(1):164. PubMed ID: 28841901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
